Neuroleptic Malignant Syndrome in a Diabetic Patient with Eye Complication and Acute Psychosis
Neuroleptic malignant syndrome is a life-threatenting complication of antipsychotic treatment. The prevalence is estimated to be 0.02 to 2.4 percent of patients exposed to dopamine receptor antagonists. Mortality rates are reported to be 10-20 percent. The important clinical signs and symptoms are...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mahidol University
1999-06-01
|
| Series: | Siriraj Medical Journal |
| Subjects: | |
| Online Access: | https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/247004 |